Suvorexant Intermediate II；2-(2H-1,2,3-TRIAZOL-2-YL)-5-METHYLBENZOIC ACID; EOS-61935；5-methyl-2-(triazol-2-yl)benzoic acid
CAS:956317-36-5
Chemical Formula:C10H9N3O2
Molecular Weight:203.20
Availability: R&D; Commercialization
⬤ CAS No.956317-36-5
⬤ Our Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid |
| CAS.No | 956317-36-5 |
| Molecular Formula | C10H9N3O2 |
| Molecular Weight | 203.2 |
| EINECS | 689-732-5 |
| Related Categories | Carboxylic acid; Suvorexan intermediate; Pharmaceutical raw materials; Organic chemical raw materials; Intermediates; Pharmaceutical raw materials |
| Melting Point | 174-176℃ |
| Boiling Point | 413℃ |
| Density | 1.35 |
| Vapor Pressure | 0-0.001Pa at 20-70℃ |
| Flash Point | 204℃ |
| Storage Conditions | Sealed in dry,Room Temperature |
| Solubility | Soluble in methanol |
| Form | Solid: Granules/Powder |
| Acidity Coefficient (pKa) | 3.00±0.36(Predicted) |
| Color | White to light yellow to light orange |
| Application | 5-Methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid is mainly used as an intermediate in organic synthesis and medicinal chemistry. It can be used in the synthesis of drug molecules and bioactive molecules, such as the synthesis of the drug molecule suvorexan. Suvorexan is a new type of hypnotic drug molecule, mainly used to treat insomnia. In organic synthesis transformation, the carboxyl group in 5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoic acid can be converted into an amide group or an ester compound under certain reaction conditions. |
| Ahout Tianming Pharmaceutical | Established in 2010, Tianming pharmaceutical is a leading manufacturer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). With state-of-the-art GMP-compliant facilities and a focus on innovation, we specialize in delivering high-quality products for global partners across oncology, cardiovascular, and antiviral therapeutics. Our robust R&D capabilities and rigorous quality control ensure compliance with international standards (ICH, FDA). Committed to sustainability and customer-centric solutions, we offer scalable production, tailored services, and timely supply chains. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
This article presents a buyer’s decision framework built on six factors: specification match, lead time predictability, total cost of ownership, batch-to-batch consistency, documentation depth, and scale-up continuity.
Switching intermediate suppliers for 20% lower price? Six hidden costs including bridging studies, regulatory filings, and method revalidation can reach $600K.
This guide decodes the seven validation parameters defined in ICH Q2(R2) from an intermediate buyer’s perspective, explains why stability-indicating methods matter for retest dating, and provides six questions buyers should ask suppliers about their analytical methods.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
